LIRENTELIMAB
UNII SWS48LJU3T

Substance Identification & Data

This profile provides standardized clinical and technical data for Lirentelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SWS48LJU3T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2283348-97-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SWS48LJU3T

CAS Registry Number

2283348-97-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIRENTELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C129591

National Cancer Institute reference terminology for clinical and research data.

INN ID

11511

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-173

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lirentelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIRENTELIMAB

Common Names & Synonyms

ANTOLIMAB

IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDINGE IG-LIKE LECTIN 8) (HUMAN-MUS MUSCULUS MONOCLONAL AK002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK002 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIALIC ACID-BINDING IG-LIKE LECTIN 8 (SIALOADHESIN FAMILY MEMBER 2, SIGLEC-8, SAF-2))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV3-66*01 (79%) (IGHD)-IGHJ5*01 (91%)/MUS MUSCULUS IGHV2-9*02 (74%) (IGHD)-IGHJ2*01 (85%))) (8.7.14) (1-120)-HOMO SAPIENS IGHG1*03 (CH3(K107>DEL(450))) (121-449)) (223-213')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-213') (HOMO SAPIENS/MUS MUSCULUS V-KAPPA (HOMO SAPIENS IGKV3-11*01 (86%) IGKJ3*01 (92%)/(MUS MUSCULUS IGKV4-57*01 (77%) IGKJ4*01 (83%))(5.3.15) (1'-106')-HOMO SAPIENS IGKC*01 (107'-213')), DIMER (229-229'':232-232'')-BISDISULFIDE

LIRENTELIMAB [INN]

LIRENTELIMAB [USAN]

LIRENTELIMAB [WHO-DD]

MONOCLONAL ANTIBODY AK002